Načítá se...
Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC
BACKGROUND: Systemic therapy is recommended for advanced non-small-cell lung cancer (NSCLC). However, conventional first-line treatment has generated a plateau in response rate of 25% to 35%. Few studies have shown patients benefit from microwave ablation (MWA) in combination with radiotherapy and c...
Uloženo v:
| Vydáno v: | Onco Targets Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4640441/ https://ncbi.nlm.nih.gov/pubmed/26604789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S90528 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|